MedTrace Logo

Drug Interaction Between Irbesartan and Hydrochlorothiazide

NCT01858610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2013-05-27

No results posted yet for this study

Summary

This study was conducted to investigate any potential reaction between irbesartan and hydrochlorothiazide.

Conditions

  • Healthy

Interventions

DRUG

Irbeasartan/hydrochlorothiazide

DRUG

Irbesartan

DRUG

Hydrochlorothiazide

Sponsors & Collaborators

  • Damanhour University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01858610 on ClinicalTrials.gov